Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

Why did Tesla shares plunge after Musk’s political move? What’s driving CoreWeave’s $9B acquisition of Core Scientific? How will Trump’s 25% tariffs impact US trade? Why is Apple appealing the EU’s $580M fine? What caused McDonald’s recent major announcement? How are Texas floods affecting local businesses? Why is Nvidia’s stock surging in 2025?

Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

benzinga.com/insights/news/25/07/46276115/heres-how-much-you-would-have-made-owning-halozyme-therapeutics-stock-in-the-last-15-years

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 2.0% on an annualized basis producing an average annual return of 14.27%. Currently, Halozyme Therapeutics has a market capitalization of $6.64 billion.
Buying $1000 In HALO: If ...
Full story…

This story appeared on benzinga.com, 2025-07-07 14:30:17.